RCW-17978-42861
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 240 / VA
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Pfizer-BioNTech
- 2021-01-21
-
2021-01-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
-
2021-02-11
Dose 2 — Pfizer-BioNTech
- 2021-02-17
- 2021-02-18
- 2021-03-06
-
2021-03-11
Survey response — day 28, dose 2MedDRA: Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to workFree text: Sore throat, runny nose, feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — day 35, dose 2MedDRA: Arthralgia — Feeling: FairFree text: Joint pain, especially kneesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech |
Free text
Release 5 — day 28, dose 2
Symptoms: Sore throat, runny nose, fever
Release 5 — day 35, dose 2
Symptoms: Joint pain, especially knees
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release